Cell‐of‐origin Determined by Both Gene Expression Profiling and Immunohistochemistry Is the Strongest Predictor of Survival in Patients With Diffuse Large B‐cell Lymphoma

American Journal of Hematology - United States
doi 10.1002/ajh.25666
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Incorporation of Digital Gene Expression Profiling for Cell-Of-Origin Determination (Lymph2Cx Testing) Into the Routine Work-Up of Diffuse Large B Cell Lymphoma

Journal of Hematopathology
Forensic MedicinePathologyHematologyHistology
2019English

Prognostic Nomogram for Overall Survival in Patients With Diffuse Large B‐Cell Lymphoma

Oncologist
Cancer ResearchMedicineOncology
2019English

The Significance of Pd-L1 and Pd1 Receptors Expression in Patients With Diffuse B-Cell Large-Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Diffuse Large B-Cell Lymphoma

2020English

KLHL6 Is a Tumor Suppressor Gene in Diffuse Large B-Cell Lymphoma

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2019English

Evaluation of Treatment Patterns and Survival Among Patients With Diffuse Large B-Cell Lymphoma in the USA

Future Oncology
MedicineCancer ResearchOncology
2019English

Clinical Significance of T-Cell Exhaustion in Patients With Diffuse Large B-Cell Lymphoma

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

B-Cell Receptor Signaling in Diffuse Large B-Cell Lymphoma

Seminars in Hematology
Hematology
2015English

Inactivation of the PRDM1/BLIMP1 Gene in Diffuse Large B Cell Lymphoma

Journal of Experimental Medicine
MedicineAllergyImmunology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy